Clinical Trial Update: Pilot Study to Evaluate Right Ventricular Function With Riociguat in CTEPH [Phase 2]

View source ↗

Summary

Phase 2 pilot study assessing the effect of riociguat on right ventricular function in chronic thromboembolic pulmonary hypertension has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thromboembolic Pulmonary Hypertension

Drugs mentioned

• Riociguat (riociguat)

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Chronic Thromboembolic Pulmonary Hypertension | Phase 2 | Status: COMPLETED